The Effect of Ruboxistaurin on Small Fiber Function

Clinical trial NCT00190970 · COMPLETED

Trial details

NCT number: NCT00190970
Sponsor: Chromaderm, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Diabetic Neuropathy

Start date: 2004-10-01
Enrollment: 52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.